A series of novel coumarin-based N-hydroxycinnamamide derivatives were designed and synthesized as histone deacetylase (HDAC) inhibitors. Most of the synthesized compounds showed potent HDAC inhibitory activity and significant antiproliferative activity against human cancer cell lines MCF-7, HepG2, HeLa and HCT-116. Among them, compound 14f displayed the most potent HDAC inhibition, especially against HDAC1 with IC value of 0.19 μM, which was better than that of SAHA (IC = 0.23 μM). It also showed the strongest antiproliferative activity towards HeLa cells and more than 26-fold selectivity for HDAC1 compared with HDAC6. Molecular docking studies revealed the possible binding modes of compound 14f into the two isoforms and provided a reasonable explanation for the selectivity. In addition, compound 14f could inhibit colony formation, upregulate the acetylation level of histone H3, and induce apoptosis and cell cycle arrest at G2/M phase in HeLa cells. Taken together, these results highlighted that compound 14f might be a promising HDAC inhibitor for cancer therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bioorg.2020.104023DOI Listing

Publication Analysis

Top Keywords

compound 14f
16
coumarin-based n-hydroxycinnamamide
8
n-hydroxycinnamamide derivatives
8
histone deacetylase
8
potent hdac
8
antiproliferative activity
8
hela cells
8
design synthesis
4
synthesis biological
4
biological evaluation
4

Similar Publications

In this present work, we describe the syntheses of a new series of 32 1H-indole-based-meldrum linked 1H-1,2,3-triazole derivatives (2-13, 15a-15f, 16a-16f, 17a-17f and 19a, 19b, 20a), which constitute a new class of 1H-1,2,3-triazoles. Compounds 15a-15f, 16a-16f, 17a-17f have been prepared by employing "click" reactions between substituted 1H-indole-based meldrum alkynes (11, 12 and 13) and substituted aromatic azides (14a-14f) in the presence of copper iodide (CuI) and Hünig's base. Then, the synthesis of compounds 19, 20 through decomposition of meldrum moiety.

View Article and Find Full Text PDF

In this work, thirty 2,4-diarylaminopyrimidine-based hydrazones were designed, synthesised, and their anti-thyroid cancer activity were explored. The majority of compounds exhibit moderate to excellent cytotoxic activity against FAK overexpressing TPC-1 cells, with IC values ranging from 0.113 to 1.

View Article and Find Full Text PDF

Design, synthesis and antitumor effects of lupeol quaternary phosphonium salt derivatives.

Bioorg Med Chem

November 2024

College of Pharmacy, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, PR China. Electronic address:

Lupeol is a natural pentacyclic triterpenoid with a wide range of biological activities. To improve the water solubility and targeting of lupeol, in the following study, we synthesized 27 lupeol derivatives in the first series by introducing lipophilic cations with lupeol as the lead compound. Through the screening of different cancer cells, we found that some of the derivatives showed better activity than cisplatin against human non-small cell lung cancer A549 cells, among which compound 6c was found to have an IC value of 1.

View Article and Find Full Text PDF
Article Synopsis
  • Crownphyrinogens and crownphyrins are macrocycles that blend features from both porphyrinoids and crown ethers, allowing for unique reactivity due to their dual-nature cavity.
  • When Ni(II) and Pd(II) are inserted into these structures, they form coordination compounds that can result in either monomeric or accordion-like dimeric assemblies, depending on the oxidation state.
  • Reactions with Na(I) and K(I) predominantly involve the crown ether segment, leading to notable dimeric complexes, and larger crownphyrins can create binuclear complexes that demonstrate distinct reactivity properties from each of its cavities.
View Article and Find Full Text PDF

Paclitaxel (PTX) is considered the blockbuster chemotherapy treatment for cancer. Paclitaxel's (PTX) oral administration has proven to be extremely difficult, mostly because of its susceptibility to intestinal P-glycoprotein (P-gp) and cytochrome P450 (CYP3A4). The concurrent local inhibition of intestinal P-gp and CYP3A4 is a promising approach to improve the oral bioavailability of paclitaxel while avoiding potential unfavorable side effects of their systemic inhibition.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!